Psoriasis patients weigh in: is wynzora cream the new favorite?
NCT ID NCT06180473
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study looked at whether people with mild-to-moderate psoriasis prefer using Wynzora cream over Enstilar foam. Thirty adults who had previously used Enstilar foam tried Wynzora cream for four weeks. Researchers used questionnaires to measure preference, treatment satisfaction, and how well patients followed their treatment plan.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Wynzora cream (calcipotriene and betamethasone dipropionate)
What this could lead to
If successful, this could show that Wynzora cream is a more preferred or easier-to-use option for managing mild-to-moderate psoriasis compared to Enstilar foam.
What could go wrong
This is a small, completed study with only 30 participants, so results may not apply to everyone. It measures preference and adherence, not long-term disease control or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Policlinico Agostino Gemelli
Rome, Italy